|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 500.50 SEK | -1.57% |
|
-8.17% | -8.83% |
| 06-30 | SEB raises Medcap price target to 630 kronor (590), reiterates buy | FW |
| 06-26 | Mildef jumps on contract news, OMXS30 index down 0.9% | FW |
Company Valuation: MedCap AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,997 | 8,899 | 8,278 | 7,517 | - | - |
| Change | - | 78.07% | -6.99% | -9.19% | - | - |
| Enterprise Value (EV) 1 | 4,997 | 9,176 | 8,359 | 7,724 | 7,444 | 7,130 |
| Change | - | 83.61% | -8.9% | -7.59% | -3.63% | -4.22% |
| P/E | 29.1x | 42.9x | - | 29x | 24.6x | 22x |
| PBR | - | 6.95x | - | 4.35x | 3.69x | 3.16x |
| PEG | - | 2.1x | - | - | 1.4x | 1.9x |
| Capitalization / Revenue | - | 4.93x | 3.93x | 3.22x | 2.97x | 2.8x |
| EV / Revenue | - | 5.08x | 3.97x | 3.3x | 2.94x | 2.65x |
| EV / EBITDA | - | 23.7x | 18.3x | 14.6x | 12.6x | 11.2x |
| EV / EBIT | - | 33.7x | 27.6x | 21.8x | 18.1x | 15.6x |
| EV / FCF | - | 28.8x | 26.4x | 227x | 22.3x | 19.4x |
| FCF Yield | - | 3.47% | 3.79% | 0.44% | 4.49% | 5.16% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 11.6 | 14 | - | 17.25 | 20.37 | 22.71 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | 1,807 | 2,108 | 2,338 | 2,531 | 2,687 |
| EBITDA 1 | - | 387.7 | 456.3 | 530 | 590 | 638 |
| EBIT 1 | - | 272.3 | 302.9 | 355 | 412 | 457 |
| Net income 1 | 172.2 | 207.4 | 219.8 | 259 | 306 | 341 |
| Net Debt 1 | - | 276.5 | 81.3 | 207 | -73 | -387 |
| Reference price 2 | 337.50 | 601.00 | 549.00 | 500.50 | 500.50 | 500.50 |
| Nbr of stocks (in thousands) | 14,807 | 14,807 | 15,078 | 15,019 | - | - |
| Announcement Date | 1/31/24 | 1/31/25 | 2/5/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 3.3x | 14.57x | - | 780M | ||
| 27.85x | 11.03x | 18.94x | 1.91% | 33.99B | ||
| 15.13x | 8.25x | 13.25x | 6.77% | 21.9B | ||
| 16.25x | 8.07x | 13.44x | 3.87% | 16.14B | ||
| 12.5x | 4.48x | 8.1x | 3.5% | 3.38B | ||
| 9.55x | 0.87x | 5.06x | 4.76% | 1.15B | ||
| 11.07x | 12.09x | 10.64x | 12.1% | 962M | ||
| 10.5x | 8.42x | 8.48x | 6.14% | 801M | ||
| Average | 14.69x | 7.07x | 11.56x | 5.58% | 9.89B | |
| Weighted average by Cap. | 20.59x | 9.14x | 15.33x | 3.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCAP Stock
- Valuation MedCap AB
Select your edition
All financial news and data tailored to specific country editions
















